" DBL-hu, a medical device dedicated to the autonomous management of highly unstable diabetes1, obtained its CE mark less than a year after the launch of its pivotal clinical trial began..." Lire la suite
Diabeloop introduces an automated management solution for highly unstable diabetes
diabeloop, 01/12/2020
Partagé par :
Beesens TEAM